During the past decade, Decatur Memorial Hospital Cancer Care Specialists of Central Illinois conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Decatur Memorial Hospital Cancer Care Specialists of Central Illinois" are "Diffuse Large B-cell Lymphoma" (1 trials), "Early Stage HER2+ Breast Cancer" (1 trials) and "Follicle Center Lymphoma" (1 trials). Many other conditions were trialed in "Decatur Memorial Hospital Cancer Care Specialists of Central Illinois" in a lesser frequency.

Most popular intervention types in "Decatur Memorial Hospital Cancer Care Specialists of Central Illinois" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Budesonide" (1 trials), "Colestipol" (1 trials), "In-111 Zevalin" (1 trials), "Loperamide" (1 trials) and "Neratinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Decatur Memorial Hospital Cancer Care Specialists of Central Illinois" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Decatur Memorial Hospital Cancer Care Specialists of Central Illinois". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Decatur Memorial Hospital Cancer Care Specialists of Central Illinois, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Decatur Memorial Hospital Cancer Care Specialists of Central Illinois, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".